Harvard and MIT researchers have developed a device that is capable of identifying single cancer cells within a blood sample, making it possible for doctors to rapidly detect circulating tumor cells.
Mehmet Toner, study leader and a professor of biomedical engineering at Harvard Medical School, along with Brian Wardle, an MIT associate professor of aeronautics and astronautics, has created an instrument that could eventually allow doctors to see if cancer has spread from its original site faster than ever.
Circulating tumor cells, which are cancer cells that escaped from the original tumor, are hard to distinguish since 1-milliliter of blood sample contains a few of them amongst tens of billions of normal blood cells.